+2
Akili Interactive Labs
For adults with ADHD and parents/caregivers of children (8-17) seeking non-pharmacological, clinically-validated cognitive treatments.
Known for
For adults with ADHD and parents/caregivers of children (8-17) seeking non-pharmacological, clinically-validated cognitive treatments.
Providing FDA-authorized and clinically-designed game-based digital therapeutics to improve attention and focus for individuals with ADHD.
Target audience
Rivals analysis in progress
Portfolio
Free 5Last updated
ADHD Insight
v1.4.4
5.5y ago
Primary focus
Game-based digital therapeutics for ADHD
Scale
indie
Target audience
Adults with ADHD and parents/caregivers of children (8-17) seeking non-pharmacological, clinically-validated cognitive treatments.
Maintained 3 active apps with 2 updates in the last 6 months, focusing development on their flagship adult and pediatric treatments.
5 apps analysed
The only FDA-authorized digital therapeutic for ADHD without a prescription.
Single-market publisher — every app ships only to United States.
Based on 1 of 5 apps with localized market data — more coverage rolling in as scans complete · last scanned .
User-sentiment analysis coming soon.
Rival analysis coming soon.
Strategic outlook coming soon.
What fed this analysis
